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Introduction {#sec1}
============

The release of insulin from pancreatic β cells is necessary for proper glucose homeostasis in mammals. β cells respond to glucose with increased oxidative metabolism, elevations in cytosolic ATP/ADP ratio, and closure of ATP-sensitive K^+^ (K~ATP~) channels ([@bib45]). The consequent plasma membrane depolarization activates voltage-dependent Ca^2+^ channels (VDCCs), leading to Ca^2+^ influx and exocytosis of secretory granules ([@bib45]).

The 3D organization of β cells is also important for the normal regulation of insulin secretion. Thus, β cells throughout the islet microorgan display rhythmic activity patterns in the presence of high glucose ([@bib4], [@bib47]). A role for specialized β cells in orchestrating these dynamics has long been postulated, including the presence of putative "pacemakers" ([@bib1], [@bib5], [@bib49]). Indeed, isolated β cells possess discrete metabolic characteristics and secretory profiles ([@bib23], [@bib24], [@bib46]), and phase lags in the onset of electrical activity can be detected between distant islet regions ([@bib4], [@bib30], [@bib34]). More recent studies have revealed functional differences between hundreds of individual β cells monitored in situ in the intact islet ([@bib21], [@bib26], [@bib51]). Such heterogeneity may be relevant for type 2 diabetes pathogenesis, since specific insults might target single cells or defined islet regions to induce insulin secretory failure. However, whether particular subsets of cells drive the behavior of others has so far been difficult to prove empirically.

Over the past decade, optogenetics has allowed reversible control of neuronal activity with light ([@bib59]). In parallel, photopharmacology has harnessed the power of azobenzene photoresponsive units to produce exogenously applied compounds that turn ion channels and G protein-coupled receptors into endogenous photoswitches ([@bib9]). As both these approaches are applicable to electrically excitable endocrine tissue ([@bib8], [@bib41]), they afford the unique opportunity to precisely manipulate cell activity with high spatiotemporal fidelity. Using all-optical interrogation of individual β cells in situ, we therefore set out to probe the topology that regulates population glucose responsiveness, with the aim of identifying the islet-resident pacemaker.

Results {#sec2}
=======

Hubs Are a Feature of β Cell Population Dynamics {#sec2.1}
------------------------------------------------

To visualize the large-scale organization of β cell activity underlying calcium (Ca^2+^)-dependent exocytosis of insulin granules, intact mouse islets were subjected to high-speed (2--8 Hz) multicellular Ca^2+^ imaging ([@bib20]). This was combined with Monte Carlo-based correlation analyses in which repeated shuffling of Ca^2+^ events (\>9,999 iterations) is used to determine whether cells are coordinated due to chance or not (i.e., contributing to the same insulin release event). Together, these approaches allow online mapping of the islet functional circuitry. Initial experiments confirmed that β cells form a scale-free network ([@bib51]), which supports the synchronous propagation of glucose (11 mM)-stimulated Ca^2+^ waves by efficiently connecting distant islet regions (R^2^ = 0.72; [Figure 1](#fig1){ref-type="fig"}A). Scale-free networks are ubiquitous throughout biology, are identified by their power law link-probability distribution ([@bib19]), and adopt a hub and spoke formation where a few cells possess the majority of connections. Accordingly, a stereotypical feature of such topology in islets was the non-random appearance of rare super-connected hubs, whose firing activity tended to repetitively precede and outlast that of the remainder of the population (i.e., was pacemaker-like) ([Figures 1](#fig1){ref-type="fig"}B and 1C) ([Movie S1](#mmc2){ref-type="supplementary-material"}).

Such islet architecture was dependent on information exchanges through gap junctions, since reversible blockade of connexin channels using 18α-glycyrrhetinic acid (AGA) ([@bib13]) reduced the number of hubs, decreased coordinated population activity, and increased signal propagation path length ([Figures 1](#fig1){ref-type="fig"}D--1G). This may reflect the inability to identify hubs due to loss of cell-cell entrainment, as well as re-routing of information over longer distances by the remaining hubs. Notably, no differences in the amplitude of Ca^2+^ rises were seen in control and AGA-treated tissue ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C), suggesting minimal impact upon VDCC activity. In all cases, parallel experiments were performed using glycyrrhizic acid (BGA), the inactive precursor of AGA that exerts similar non-specific effects ([@bib11]). Results could be replicated using mebeverine ([@bib13]) ([Figure S1](#mmc1){ref-type="supplementary-material"}D), a gap junction inhibitor with no reported effects on VDCC or K~ATP~ channel activity, as well as *Gjd2* shRNA to specifically silence connexin-36 at the islet surface ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1H).

Hubs Are Stable and Present across Species {#sec2.2}
------------------------------------------

To assess network topology stability, islets were recorded and then left on the microscope for between 30 min and 3 hr before re-recording. Network topology was stable both over time and in response to perturbation, as statistically assessed versus a third experiment subjected to either randomization (i.e., to re-distribute the wiring pattern) or enforced-dissimilarity (i.e., to form a different wiring pattern) ([Figures 1](#fig1){ref-type="fig"}H and 1I). Network indices were unaffected in the presence of either a specific glucagon receptor antagonist ([Figures S1](#mmc1){ref-type="supplementary-material"}I and S1J) or a glucagon-neutralizing antibody ([Figures S1](#mmc1){ref-type="supplementary-material"}K and S1L), suggesting that any glucagon present in vitro is unlikely to influence hub function. Hinting at a conserved role for hub architecture, islet functional topologies were similar in glucose-stimulated mouse and human islets, as shown by the similar link-probability distributions (i.e., both are fitted with a power law of near-identical exponent value) ([Figure 1](#fig1){ref-type="fig"}J). However, synchrony tended to be compartmentalized into subregions/clusters in human islets ([Figure 1](#fig1){ref-type="fig"}J), in line with the different structural arrangement of β versus α cells in this species ([@bib7]). β cell Ca^2+^ responses were not dependent on orientation toward the islet center or periphery (ΔY Fluo2 = 0.14 ± 0.01 versus 0.13 ± 0.004 AU, periphery versus center, respectively), and identical results were obtained using the geneticall encoded indicator GCaMP6 ([Figures 1](#fig1){ref-type="fig"}K and 1L), engineered to interfere less with intracellular Ca^2+^ levels.

A Strategy for All-Optical Interrogation of β Cell Function {#sec2.3}
-----------------------------------------------------------

To functionally dissect the role of hubs, an optogenetic strategy was developed and validated, enabling electrical silencing following *Ins1Cre*-directed expression of the light-gated chloride (Cl^−^) pump halorhodopsin (eNpHR3.0) ([@bib59]) in β cells ([Figures 2](#fig2){ref-type="fig"}A and 2B). This approach allowed the reversible silencing of single β cell or population Ca^2+^-spiking activity and extracellular Ca^2+^ influx following illumination (λ = 560--590 nm) ([Figures 2](#fig2){ref-type="fig"}C--2G) ([Movies S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}). Application of the depolarizing agent potassium chloride was able to overcome silencing by restoring VDCC activity ([Figure 2](#fig2){ref-type="fig"}H). Of note, wild-type β cells were refractory to silencing ([Figures 2](#fig2){ref-type="fig"}I and 2J), and eNPHR3.0-expressing β cells under irradiation were not further hyperpolarized using diazoxide to force open K~ATP~ channels ([Figure 2](#fig2){ref-type="fig"}K). As measured using patch-clamp electrophysiology, illumination induced photocurrents ([Figure 3](#fig3){ref-type="fig"}A), leading to membrane hyperpolarization and electrical silencing only in eNPHR3.0-expressing β cells ([Figures 3](#fig3){ref-type="fig"}B--3D). Thus, specific and powerful optogenetic silencing could be achieved.

Animals harboring a single eNpHR3.0 allele unexpectedly demonstrated improved glucose tolerance compared to wild-type littermates, despite normal insulin sensitivity ([Figures 4](#fig4){ref-type="fig"}A--4F) and body weight/growth curves ([Figures 4](#fig4){ref-type="fig"}G and 4H). This was probably due to enhanced in vivo insulin secretion ([Figure 4](#fig4){ref-type="fig"}I), as β cell mass was apparently normal ([Figure 4](#fig4){ref-type="fig"}J). Activation of eNpHR3.0 on an Ins1Cre background also led to similar results, suggesting that alternation in insulin gene dosage in the context of the transgene was unlikely to be a contributing mechanism ([Figures 4](#fig4){ref-type="fig"}K and 4L). Pertinent to the in vitro studies here, however, isolated islets responded normally to glucose in terms of ionic fluxes and insulin release ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2I), and eNpHR3.0 does not possess basal activity in the absence of light ([@bib59]) (also shown in [Figure 3](#fig3){ref-type="fig"}C).

Hubs Orchestrate β Cell Population Responses to Glucose {#sec2.4}
-------------------------------------------------------

By performing analysis in real-time using islets maintained on the microscope stage, hubs could be identified and subsequently manipulated ([Figures 5](#fig5){ref-type="fig"}A--5C). Silencing of individual hubs using a pinpointing laser had catastrophic consequences for coordinated islet responses to high glucose ([Figures 5](#fig5){ref-type="fig"}D and 5E) ([Movies S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc7){ref-type="supplementary-material"}), an effect reversed simply by ceasing illumination ([Figures 5](#fig5){ref-type="fig"}F and 5G). The strength of inhibition following targeting of individual hubs tended to be inversely associated with the number of these cells per islet before silencing ([Figure S2](#mmc1){ref-type="supplementary-material"}J), suggesting that some redundancy is present in the system, most likely due to follower cells being controlled by more than one hub. By contrast, silencing of individual non-hub or follower cells did not significantly perturb islet dynamics ([Figure 5](#fig5){ref-type="fig"}H), demonstrating the specificity of the approach.

Using a similar technique, hubs were first identified at high glucose, before inactivation using low glucose and stimulation with JB253, an exogenously applied K~ATP~ channel photoswitch based on glimepiride ([@bib8]). Following targeted illumination of JB253-treated islets, hub connectivity could be mimicked without activation of intervening cells, as determined by the presence of glucose- and gap-junction-dependent entrainment patterns in follower cells (conduction velocity = 47.0 ± 8.9 μm/s) ([Figures 5](#fig5){ref-type="fig"}I--5K). Such effects were unlikely to stem from diffusion of active JB253, since this molecule turns off within milliseconds in the dark ([@bib8]), and proximate cells remained unaffected by hub stimulation ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3D).

Hubs Are Required for Insulin Secretion {#sec2.5}
---------------------------------------

We were unable to measure insulin secretion accurately from a single islet over the 5 min experimental period used here, since levels were below the detection sensitivity of current assays. Therefore, to link hub activity with hormone release, the cell-surface-attached fluorescent Zn^2+^ probe JP-107 ([@bib35]) was instead employed as a surrogate to dynamically report Zn^2+^ co-released with insulin from cells at the islet surface, as previously reported with ZIMIR ([@bib26]). Using this approach, silencing of follower cells or wild-type islets was without effect, as evidenced by a linear increase in fluorescence due to Zn^2+^ accumulation at the probe. By contrast, hub shutdown or global illumination lowered insulin/Zn^2+^ release to below the dissolution rate of the probe (i.e., Zn^2+^ binding is lower than Zn^2+^ removal) ([Figure 5](#fig5){ref-type="fig"}L).

While it was not technically possible to directly link hub activity with pulsatile insulin release, the acetylcholinomimetic carbachol ([@bib60]) was able to accelerate β cell population activity ([Figure S3](#mmc1){ref-type="supplementary-material"}E) without altering the proportion of links or hubs ([Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G). Moreover, rapid imaging performed over dozens of minutes---i.e, within the range of insulin pulses ([@bib18])---revealed that hubs are also a feature of population behavior over longer periods (proportion hubs = 7.1% ± 1.3%; proportion links = 9.7% ± 2.0%). Since carbachol has been shown to phase-set activity between islets in vitro ([@bib60]), parasympathetic neurons may plausibly target hubs in vivo to synchronize islet activity and generate insulin pulses.

Hubs Possess a Characteristic Metabolic Signature {#sec2.6}
-------------------------------------------------

We next sought to understand what makes a hub cell unique. Islet-wide Ca^2+^ signals were recorded before metabolic profiling of the hub population in the same islet using the mitochondrial potential dye tetramethylrhodamine ethyl ester (TMRE), which sequesters in active, hypeporlarized mitochondria. Following stimulation at high glucose, mitochondria in hubs became more hyperpolarized versus those in non-hubs ([Figures 6](#fig6){ref-type="fig"}A and 6B), suggesting increased proton pumping, ATP synthase activity, and ATP generation ([@bib54]). While the duty cycle (i.e., proportion of time the cell spends "ON") was slightly increased in hubs compared to non-hubs ([Figure 6](#fig6){ref-type="fig"}C), other activity parameters including Ca^2+^-spiking amplitude and frequency were broadly similar ([Figures 6](#fig6){ref-type="fig"}D--6F). Spatially, hubs and non-hubs were intermingled, with no clear preference for the islet center or periphery detected for either population based on polar coordinates (angle and distance taken from the islet center) ([Figures 6](#fig6){ref-type="fig"}G and 6H).

Hubs Display Features of both Mature and Immature β Cells {#sec2.7}
---------------------------------------------------------

Using photoactivatable Tag-RFP (PA-TagRFP) to photopaint single hubs within islets using a 405 nm laser ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B), post hoc immunostaining against a variety of markers of β cell "identity" ([@bib45]) could be performed ([Figure 6](#fig6){ref-type="fig"}I) without adversely altering Ca^2+^ dynamics ([Figure S4](#mmc1){ref-type="supplementary-material"}C). These studies revealed reduced insulin content, increased glucokinase (Gck) levels, lowered expression of pancreatic duodenum homeobox-1 (Pdx1), but normal levels of the mitochondrial import receptor subunit TOM20 homolog (Tomm20) in hubs versus the rest of the population ([Figures 6](#fig6){ref-type="fig"}I and 6J) ([Figure S5](#mmc1){ref-type="supplementary-material"}). The transcription factor NK6 homeobox 1 (Nkx6.1), recently shown to be required for insulin biosynthesis and β cell proliferation ([@bib55]), was almost absent from hubs ([Figures 6](#fig6){ref-type="fig"}I and 6J). Suggesting that hubs are unlikely to represent a multihormonal (e.g., Glu+, Ins+) population, no co-localization with glucagon was detected ([Figure 6](#fig6){ref-type="fig"}K). Likewise, neurogenin 3 (Ngn3), a β cell precursor marker, was undetectable at the protein level in the adult islet, implying that hubs are unlikely to be trapped in a progenitor state ([Figure 6](#fig6){ref-type="fig"}K). Inspection of oversampled and deconvolved superresolution confocal images revealed no differences in mitochondrial distribution/shape or endoplasmic reticulum content in hubs ([Figures 6](#fig6){ref-type="fig"}L--6P), although expression of the sarco(endo)plasmic reticulum Ca^2+^/ATPase, SERCA2, was markedly reduced ([Figures 6](#fig6){ref-type="fig"}O and 6P).

Suggesting a hyposecretory (or degranulated) nature, insulin granule numbers were lower in hubs versus non-hubs, despite a similar distribution ([Figures 6](#fig6){ref-type="fig"}Q and 6R). Furthermore, the area of individual hub cells was comparable to the rest of the population (range = 122--381 μm^2^ and 194--355 μm^2^, non-hubs versus hubs, respectively), and their shape appeared to be normal. Consequently, hubs constitute a metabolically adapted, repurposed subpopulation of β cell that displays features of immature cells.

Hubs Are Targeted by Diabetic Milieu {#sec2.8}
------------------------------------

Lastly, the robustness of hubs was determined by challenging islets with cytokine cocktails (IL-1β/IL-6 or IL-1β/TNF-α) to re-create the pro-inflammatory milieu thought to be associated with diabetes ([@bib33]). Acutely, the application of cytokines led to a large ramp-up in Ca^2+^ spiking activity in the presence of high glucose ([Figure S6](#mmc1){ref-type="supplementary-material"}). However, after only 2 hr incubation, a collapse in hub cell number was apparent ([Figures 7](#fig7){ref-type="fig"}A and 7B), and this could be viewed in real-time by recording the same islet left in situ before and during exposure to cytokine (IL-1β/IL-6) ([Figures 7](#fig7){ref-type="fig"}C and 7D). The cytokine-induced disruption to hub cell function was further evidenced by a reduction in the number of cells occupying the upper or "high connectivity" region of the link-probability distribution ([Figures 7](#fig7){ref-type="fig"}E and 7F), as shown by a decrease in the exponent value of the power law fit. This resulted in a dramatic decline in correlated β cell population function ([Figure 7](#fig7){ref-type="fig"}G) due to the presence of fewer and less well-connected hubs. The actions of cytokines were not explained by effects on cell viability, as assessed using indices of necrosis ([Figures 7](#fig7){ref-type="fig"}H and 7I) and apoptosis ([Figure 7](#fig7){ref-type="fig"}J). However, 2 hr cytokine exposure decreased mRNA levels of the major islet gap junction isoform connexin-36 (*Gjd2*) 3-fold ([Figures 7](#fig7){ref-type="fig"}K and 7L), and this was already associated with a substantial reduction in gap junction plaque number ([Figure 7](#fig7){ref-type="fig"}M), in line with that recently reported using a similar paradigm ([@bib14]). Likewise, preferential hub failure was detected in both rodent and human tissue in response to gluco(lipo)toxic insults ([Figures 7](#fig7){ref-type="fig"}N and 7O).

Discussion {#sec3}
==========

β cells are a phenotypically diverse population, presenting a mosaic of metabolic and electrical activity patterns ([@bib38]), which is mirrored at the level of insulin secretory capacity ([@bib23], [@bib24], [@bib26], [@bib46]). When viewed as a population, β cells are often termed a functional syncytium, although a role for cell heterogeneity in generating multicellular dynamics has been invoked repeatedly ([@bib3], [@bib51]). Indeed, it has been shown that a subset (∼10%--15%) of β cells may exert a disproportionate influence over islet dynamics ([@bib22]). By combining large-scale functional cell mapping with optogenetics and photopharmacology, we provide here a revised blueprint for islet function whereby a few pioneer hubs with reduced β cell identity dictate emergent population behavior in response to glucose. Importantly, hub topologies are a feature of dynamical systems, including cell networks in the brain and pituitary ([@bib6], [@bib20]), since they are functionally robust at a low wiring cost ([@bib10]) (i.e., the chances of randomly hitting a hub are low). However, should a hub be specifically targeted, the effects on cell population function are far reaching, as observed in the islet during exposure to cytokine or glucolipotoxicity.

The present study used a single-photon-based confocal system to control the activity of individual hubs or followers within isolated islets. While two photon approaches in theory increase the accuracy of cell targeting by restricting the beam to within a few microns of the focal point, there are drawbacks when used with optogenetics. First, a diffraction-limited two-photon laser spot (i.e., ∼500 nm) is insufficient to reliably activate optogenes, and the long excited state halftime can quickly saturate the rhodopsin ([@bib42]). Second, commercial lasers are unable to deliver the \>1,100 nm excitation required for eNpHR3.0 activation without an optical-parametric oscillator ([@bib2]). By contrast, a single-photon diffraction-limited laser spot (∼500 nm) of known absorbance cross-spectrum can be introduced to the surface of the sample, with minimal aberration and steep power drop-off as a function of 1/distance^2^. Demonstrating the high degree of localization of the effective beam, we were clearly able to photopaint single cells within an islet and did not see any population silencing when a follower cell was targeted.

Using patch-clamp recordings of dissociated β cells, eNpHR3.0 activation hyperpolarized membrane potential by −60 mV, in line with previous reports ([@bib29]). While photocurrent size may be underestimated due to the presence of an electrochemical gradient, it should be noted that halorhodopsin derives energy from photons rather than the ion gradient itself ([@bib36]), and the photocycle is unaffected even in the presence of high Cl^−^ concentration ([@bib58]). In any case, it is unlikely that hyperpolarizing spread throughout the islet per se could account for these observations, since (1) only 30% of voltage spreads to an immediately coupled cell and an 86 mV depolarizing step is required for activation via gap junctions ([@bib61]); and (2) stimulation of follower cells was without effect. We prefer an explanation whereby large changes in conductance attributable to the hub cell or its very close neighbors are removed through eNpHR3.0-mediated silencing, leading to impaired propagation of Ca^2+^ waves ([@bib3], [@bib4], [@bib61]). Although membrane potential was slightly more depolarized following cessation of illumination, this is also seen in neurons ([@bib29]) and may reflect the reversal potential of Cl^−^. We did not notice significant effects on hub indices during the Ca^2+^ imaging studies here due to use of a 5--10 min "rest" period to allow Cl^−^ re-equilibration.

Experiments in which hub cells were stimulated revealed that hubs and followers are unlikely to form local syncytia. While the exact mechanisms for antipodal signal propagation are difficult to determine precisely, a role for 3D chains of electrically coupled cells is plausible, given that entrainment was markedly blunted by both gap junction blockade and perfusion with 1 mM glucose. Other communication possibilities include autonomic neurons, which possess \>100 μm axonal arborizations in pancreatic slices ([@bib43]), and cilia, which provide a restricted signaling corridor due to their presence in only ∼25% of β cells ([@bib17]). Along these lines, the effect of hub silencing on islet function was surprisingly strong, given the relatively mild phenotype of animals deleted for the gap junction protein connexin36 ([@bib40]). However, considerable redundancy exists in the latter model with connexin-30.2 (Cx30.2) and ephrins providing alternative signaling routes ([@bib12], [@bib25]).

An intriguing possibility is that hubs are related to the previously described Pdx1+, Ins(low) β cell subpopulation ([@bib53]), albeit distinct in their low levels of both markers. Impaired identity, while conceivably restraining stimulus-induced secretion, may also limit GK-induced proliferation ([@bib37], [@bib50]) to maintain the role of these cells as specialized pacemakers. Indeed, high levels of GK expression may sensitize hubs cells to increases in glucose concentration, allowing these cells to respond earlier and more robustly than their neighbors. By contrast, the failure of hubs when faced with a gluco(lipo)toxic/pro-inflammatory milieu indicates that these cells are metabolically fragile. This vulnerability might reflect high Gck/*Gck* ([@bib44]) expression coupled to low Pdx1 and SERCA2 levels ([@bib15], [@bib16]), which ultimately lead to ER stress and cell dysfunction.

We acknowledge that the hub protein characterization performed here constitutes a biased screen, but it nonetheless provides a strong foundation for understanding the biology of these unusual cells. In the future, unbiased multiplex approaches, including massive parallel sequencing (RNASeq) and CyTOF (single cell mass cytometry) ([@bib39]), will help define the hub signature. Although attempts were made to obtain dissociated cells/cytoplasm for these purposes, PA-TagRFP fluorescence disappeared following dissociation of islets, possibly reflecting either the fragility of these cells, or the fluorophore itself. Similar problems were encountered with electron microscopy, where available antibodies cannot differentiate between activated and non-activated PA-TagRFP.

The recording approaches used to monitor hubs were technically constrained to 2 to 3 hr. Indeed, such experiments necessitate leaving the islets in situ on the microscope, since the same field of view must be maintained for analysis purposes. Thus, it cannot be excluded that hubs may represent a transitory subpopulation that drifts over dozens of hours in line with transcriptional/translational processes. Indeed, modeling studies predict that "pacemakers" arise from the most excitable β cell, which is assumed to shift due to a random distribution of excitability as K~ATP~ channel expression levels vary ([@bib5]). However, the possibility that such cells may arise during development could not be excluded ([@bib5]), and studies in FACS-purified GFP-labeled β cells suggest the presence of distinct transcriptional pools, with the proportions remaining similar between animals and days ([@bib23]). Moreover, to the best of our knowledge, there is no evidence that K~ATP~ channel levels change over time, though the presence of a substantial proportion of channel subunits on internal membranes ([@bib57]) may complicate such measures.

Lastly, it should be noted that experiments in isolated islets may not necessarily reflect the situation in vivo, where blood flow direction (β cell→α cell) ([@bib32]) and molecule access dynamics ([@bib31]) may all affect the role of hubs in dictating population dynamics and insulin secretion. This possibility might be tested in the future using in vivo imaging approaches ([@bib32], [@bib48]).

In summary, the present findings provide new insights into the regulation of islet function by individual β cells and the mechanisms that likely target and impair this during type 2 diabetes pathogenesis and treatment. More generally, the paradigm developed here to study the roles of individual cells within the functioning islet may be broadly applicable to other tissues or organisms.

Experimental Procedures {#sec4}
=======================

Animals, Glucose/Insulin Tolerance Testing and Insulin Measures {#sec4.1}
---------------------------------------------------------------

β-cell-specific expression of halorhodopsin was achieved by crossing the Ins1Cre deletor strain ([@bib56]) with animals engineered to express eNpHR3.0-EYFP following excision of a *loxP-*flanked STOP cassette (B6;129S-Gt(ROSA)26Sortm39(CAG-hop/EYFP)Hze/J). *Ins1Cre*^+/−^ and *Ins1Cre*^−/−^ littermates (i.e., derived from an *Ins1Cre*^−/−^ × *Ins1Cre*^+/−^ breeding pair) display similar glucose tolerance and growth curves ([@bib56]), as well as insulin tolerance, in vivo and in vitro insulin secretion, and β cell mass ([Figure S7](#mmc1){ref-type="supplementary-material"}). For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Islet Isolation {#sec4.2}
---------------

Islets were isolated using collagenase digestion and cultured for 24--72 hr in RPMI medium supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 μg/ml streptomycin.

Human Islet Culture {#sec4.3}
-------------------

Human islets were obtained from isolation centers in Italy and Switzerland, with necessary local and national ethical permissions, including consent from the next of kin. Islets were cultured in RPMI supplemented with 10% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.25 mg/ml fungizone, supplemented with 5.5 mM *D*-glucose. Ethical approval was granted by the National Research Ethics Committee London (Fulham), REC \#07/H0711/114.

Calcium and Mitochondrial Potential Imaging {#sec4.4}
-------------------------------------------

Multicellular Ca^2+^ and mitochondrial potential imaging was performed as detailed in [@bib21]. Mitochondrial potential was monitored using TMRE. For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Electrophysiology {#sec4.5}
-----------------

Pancreatic islets were dissociated into single β cells and plated onto glass coverslips. Electrophysiological recordings were performed in either perforated patch-clamp or whole-cell configuration using an EPC9 patch-clamp amplifier controlled by Pulse acquisition software (HEKA). For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Dynamic Insulin Secretion Measures {#sec4.6}
----------------------------------

Zinc (Zn^2+^) co-released from insulin-containing granules was measured as a proxy for insulin secretion using the chemical probe JP-107 (300 μM), as described in [@bib35]. For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Generation of Adenoviral PA-TagRFP and Photopainting {#sec4.7}
----------------------------------------------------

cDNA encoding the photoactivatable fluorescent protein PA-TagRFP ([@bib52]) was cloned into pShuttleCMV *via Xho 1* and *Xba I* sites before recombination with pAdEasy1 and virus production as described in [@bib27]. Islets were incubated for 48 hr with adenovirus harboring PA-TagRFP at a MOI = 100. For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

shRNA-Silencing of Connexin-36 {#sec4.8}
------------------------------

For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Immunohistochemistry {#sec4.9}
--------------------

Islets were fixed at 4°C overnight in paraformaldehyde (4%, wt/vol) before permeabilization (PBS + Triton 0.1%) and application of primary and secondary antibody for 24--48 hr at 4°C. Connexin-36 staining was performed as above, but following 10 min fixation in ice-cold acetone. For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

β and α Cell Mass {#sec4.10}
-----------------

For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Necrosis and Apoptosis Assays {#sec4.11}
-----------------------------

For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Real-Time PCR {#sec4.12}
-------------

Relative mRNA abundance was determined on an Applied Biosystems ABI 7500 Fast Real-Time PCR System using SYBR Green reagents and primers against connexin 36 (*Gjd2*) (GATTGGGAGGATCCTGTTGAC and AGGGCTAGGAAGACAGTAGAG). Gene expression was normalized to β-actin (CGAGTCGCGTCCACCC and CATCCATGGCGAACTGGTG) and fold-change in mRNA expression compared to control was calculated using the 2^−ΔΔCT^.

Correlation, Similarity Analyses and Polar Coordinates {#sec4.13}
------------------------------------------------------

Individual EYFP-expressing β cells were identified using an ROI to produce a mask overlay of the imaged population. Correlation analyses were then performed in MATLAB on Hilbert-Huang transformed Ca^2+^ signals using binarization and matrix analyses, and statistical significance assigned using non-deterministic (Monte-Carlo) methods, as described ([@bib19], [@bib20]). For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Measurements of Insulin Secretion from Isolated Islets {#sec4.14}
------------------------------------------------------

For detailed information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Cytokines and Glucolipotoxicity {#sec4.15}
-------------------------------

Interleukin 1 β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor α (TNF-α) (all from R&D Biosystems) were stored as stock solutions at −20°C and used at 20 pg/ml, 40 pg/ml, and 20 pg/ml, respectively ([@bib28], [@bib33]). For gluco(lipo)toxicity studies, cells were exposed to 33 mM glucose and/or 0.5 mM BSA-conjugated palmitate for 48 hr.

Statistical Analyses {#sec4.16}
--------------------

Data normality was assessed using the D'Agostino Pearson omnibus test. Pairwise comparisons were performed using paired or unpaired Student's t test. Interactions between multiple treatments were determined using one-way or two-way ANOVA (adjusted for repeated-measures as necessary), followed by pairwise comparisons with Bonferonni's or Tukey's posthoc tests. Analyses were conducted using R (R Project), Graphpad Prism 6.0 (Graphpad Software), IgorPro (Wavemetrics), and MATLAB (Mathworks), and results deemed significant at p \< 0.05. Unless otherwise stated, data are presented as the mean ± SEM.
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![Functional Mapping of β Cell Population Dynamics\
(A) At elevated glucose (11 mM), islets house a scale-free network where a few (\<10%) β cells host the majority of correlated links (p \< 0.01), as shown by the power law-fitted probability distribution (LC, low connectivity range; HC, high connectivity range) (R^2^ = 0.72) (n = 12 recordings from five animals). A log-log scale is used to convert the power law into a linear relationship.\
(B) Representative functional connectivity map displaying the x-y position of analyzed cells and their links (followers, blue; hubs, red; scale bar, 20 μm).\
(C) Representative trace showing that hub (red) activity tends to precede and outlast that of follower cells (gray) (mean lag value calculated from n = 5 recordings from three animals).\
(D) Treatment of islets with the gap junction blocker 18α-glycyrrhetinic acid (AGA; 20 μM) (left), but not its inactive analog glycyrrhizic acid (BGA; 20 μM) (right) reduces the proportion of hubs (n = 9 recordings from five animals) (before, islet in control buffer; after, same islet in the presence of either AGA or BGA).\
(E) As for (D), but the proportion (%) of correlated links.\
(F and G) Gap junction blockade increases the length between correlated links (n = 9 recordings from five animals).\
(H) Wiring patterns are statistically stable upon re-recording after 30 min, as determined against the same islet but with enforced dissimilarity (n = 8 recordings from five animals).\
(I) Wiring patterns are statistically stable upon re-recording after 30 min (Fluo2) and 3 hr (GCaMP6), as compared to the randomly shuffled correlation matrix for each islet (n = 4--6 recordings from two to three animals).\
(J) As for (A) but showing almost identical link-probability distributions in mouse and human islets, as shown by the exponent values (κ) for the fitted power laws (n = 8 recordings from three donors).\
(K and L) Imaging using GCaMP6 and Fluo2 return similar hub and link proportions (n = 12 recordings from four to six animals).\
Data are means ± SEM.^∗^p \< 0.05 and ^∗∗^p \< 0.01. NS, non-significant. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Movie S1](#mmc2){ref-type="supplementary-material"}.](gr1){#fig1}

![Reversible and Repeated Silencing of β Cell Ca^2+^-Spiking Activity\
(A) Immunostaining for insulin showing membrane-localized expression of eNpHR3.0-EYFP in β cells (Dapi, nuclei) (n = 3 preparations).\
(B) As for (A), but immunostaining for glucagon showing absence of eNpHR3.0-EYFP in α cells (n = 3 preparations). Scale bar, 50 μm (or 10 μm for dissociated cells).\
(C) Reversible silencing of β cell Ca^2+^ oscillations in eNpHR3.0-expressing islets in response to illumination with λ = 561 nm (n = 5 recordings). Treatment of islets with nifedipine 50 μM (Nif; black trace) abolishes the rebound in Ca^2+^ upon inactivation of eNpHR3.0 (n = 5 recordings) (traces are from different islets).\
(D) As for (C), but in the presence of verapamil 10 μM (Ver; black trace) (n = 5 recordings) (traces are from different islets).\
(E) Perifusion of islets with zero Ca^2+^ supplemented with EGTA was able to prevent recovery of \[Ca^2+^\]~i~ in islets following silencing (n = 5 recordings).\
(F) β cell population Ca^2+^-spiking activity can be repeatedly silenced following exposure to λ = 561 nm (n = 3 recordings).\
(G) Global silencing (λ = 561 nm) induced a decrease in intracellular Ca^2+^ concentrations (\[Ca^2+^\]~i~) throughout the islet, whereas a diffraction-limited laser (λ = 589 nm) only silenced \[Ca^2+^\]~i~ in the targeted area (n = 3 recordings).\
(H) Silencing can be overcome using the depolarizing agent KCl 30 mM to re-activate VDCC (n = 6 recordings).\
(I and J) Wild-type islets (*NpHR*^−/−^) do not respond to illumination with decreases in \[Ca^2+^\]~i~ (n = 5 recordings).\
(K) Diazoxide (Dz) 100 μM is unable to further suppress \[Ca^2+^\]~i~ in eNpHR3.0-silenced islets (n = 5 recordings).\
Where indicated, tolbutamide (Tb) 100 μM was added to maintain a stable plateau from which to better detect silencing. G17, glucose 17 mM; G11, glucose 11 mM; G3, glucose 3 mM. See also [Movies S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}.](gr2){#fig2}

![Yellow Light Hyperpolarizes eNpHR3.0-Expressing Pancreatic β Cells\
(A) Voltage clamp (whole cell) recording of an eNpHR3.0-expressing β cell showing induction of photocurrents with yellow light (λ = 572 nm).\
(B--D) Representative current clamp (perforated patch) recordings showing reversible membrane hyperpolarization with yellow light (λ = 572 nm) in an eNpHR3.0-expressing (NpHR), but not wild-type (WT), β cell. In all cases, n = 6--11 cells.\
Data are means ± SEM. ^∗∗∗^p \< 0.001.](gr3){#fig3}

![Glucose Homeostasis in eNpHR3.0 Mice\
(A and B) Glucose tolerance is improved in male 8 week *Ins1Cre*^+/−^;*eNpHR3.0-EYFP*^fl/−^(NpHR) animals (n = 7) compared to *Ins1Cre*^−/−^;*eNpHR3.0-EYFP*^fl/−^ (wild-type, WT) littermates (n = 7) (i.e., activation of Ins1Cre on an eNpHR3.0-EYFP background), as assessed using IPGTT.\
(C) Insulin sensitivity is similar in male NpHR mice animals and WT littermates (n = 6--11), as determined using ITT.\
(D and E) As for (A) and (B), but female 8 week mice (n = 7--9).\
(F) As for (C), but female 8 week (n = 4).\
(G and H) Fasting body weight and growth curves (non-fasted) are similar in WT and NpHR animals (n = 9--13).\
(I) In vivo insulin release tended to be increased in NpHR compared to WT animals at 15 min post-IP glucose injection (n = 4).\
(J) β cell mass, α cell mass, and α:β cell ratio are similar in WT and NpHR animals (n = 3).\
(K and L) As for (A) and (B), but glucose tolerance in 6 and 8 week *Ins1Cre*^+/−^;*eNpHR3.0-EYFP*^fl/−^(NpHR) (n = 3--4) compared to *Ins1Cre*^+/−^;*eNpHR3.0-EYFP*^−/−^ (wild-type, WT) animals (n = 8) (i.e., activation of eNpHR3.0-EYFP on an Ins1Cre-background).\
Data are means ± SEM. ^∗∗^p \< 0.01. NS, non-significant. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Real-Time Analysis and Targeting of β Cell Hubs\
(A and B) Schematic showing the effects of eNpHR3.0 activation upon β cell Ca^2+^ signaling (A), and snapshot showing placement of a diffraction-limited laser spot over a discrete islet region (B) (scale bar, 25 μm; image cropped to display a single islet).\
(C) Experimental flowchart for real-time manipulation of hub function.\
(D--F) Representative functional connectivity map and activity plots at high glucose (11 mM), before (D), during (E) and after (F) optogenetic silencing (identified hub cell; red). A representative Ca^2+^ trace is displayed above.\
(G and H) Summary data showing a reversible collapse in the proportion of correlated cell links following hub (G), but not follower (or non-hub) (H) silencing (n = 7--9 recordings from four animals).\
(I--K) Representative cell-cell entrainment patterns (I) and representative Ca^2+^ rises in linked cells (J) following photopharmacological stimulation of an identified hub (red) at 3 mM glucose using JB253 (50 μM). Box and whiskers plot shows the range and mean number of hub- or follower-entrained cells under high (11 mM) glucose (High Glu) conditions, and following targeted stimulation using JB253 in the presence of control (3 mM glucose), BGA, AGA, and low (1 mM) glucose (low Glu) (K) (n = 4--7 recordings from three to four animals).\
(L) Insulin secretion measured using JP-107 is unaffected following illumination of follower (or non-hub) cells or wild-type (WT) islets, but suppressed in response to hub or islet (global) shutdown (mean traces shown) (n = 8 islets from 4 animals).\
Scale bars, 20 μm. Data are means ± SEM. ^∗^p \< 0.05. NS, non-significant. See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"} and [Movies S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc7){ref-type="supplementary-material"}.](gr5){#fig5}

![Phenotypic Profiling of Hub Cell Function\
(A and B) Hubs display elevated mitochondrial potential (Ψm) compared to the rest of the population, as measured using TMRE to label active mitochondria (n = 9 recordings from three animals) (G3, glucose 3 mM; G11, glucose 11 mM) (fold-change is normalized to all cells).\
(C--F) Duty cycle (i.e., fraction spent "ON") (C) and Ca^2+^ oscillation amplitude (D) and frequency (\[E\], \[F\]) are similar in hubs and followers (n = 8 recordings from four animals).\
(G and H) Polar coordinates showing that hub distribution is not spatially biased versus followers (angle θ and distance r from the islet center 0,0 are shown in the bar graphs).\
(I and J) PA-TagRFP-identified hubs (red; RFP) express less insulin (Ins), less Pdx1, less Nkx6.1, more Gck, and normal Tomm20 compared to the rest of the population (n = 5--9 hubs from three to four animals).\
(K) Hubs were not immunopositive for glucagon (Glu), and Ngn3 expression was largely undetectable in the adult islet.\
(L--N) High resolution Z projections of Tomm20- and MitoTracker-stained islets (L) reveal normal mitochondrial sphericity (M) and length (N) (white-dashed line, hub; blue-dashed line, non-hub) (3D render shown for Tomm20 and Z projection for MitoTracker) (n = 6 hubs from three animals).\
(O and P) As for (L)--(N), but staining for Pdi and SERCA2 showing normal endoplasmic reticulum abundance and lowered Ca^2+^-ATPase content in hubs (Z projection, left; 3D render, right) (n = 4 to 5 hubs from three animals).\
(Q and R) High-resolution snapshot of insulin staining (Q) showing a reduction in granule content in hubs (red) (R) (n = 6 hubs from three animals). Scale bars, 12.5 μm.\
Data are means ± SEM. ^∗^p \< 0.05 and ^∗∗^p \< 0.01. NS, non-significant. See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}

![Disruption of Hubs by Pro-Inflammatory and Glucolipotoxic Insults\
(A and B) IL-1β/IL-6 and IL-1β/TNF-α reduce hub number after 2 hr (n = 6 islets from three animals).\
(C and D) Cytokine (Cyto; IL-1β/IL-6) decreases hub number in real-time (n = 8 from four animals).\
(E and F) Cytokine alters the distribution of correlated links and power law scaling exponent (*k*) value, indicating a decreased number of cells in the high connectivity (i.e., hub) range (n = 8 from four animals) (R^2^ = 0.38--0.74). The power law was log-log transformed to a linear relationship to better demonstrate the distribution.\
(G) Cytokine (IL-1β/IL-6) exposure dramatically reduces the proportion of correlated links.\
(H to I) Application of IL-1β/IL-6 or IL-1β/TNF-α for 2 hr (H) or 4 hr (I) is not cytotoxic (n = 21 islets per condition from 6 animals) (scale bar, 25 μm).\
(J) 2 hr application of IL-1β/IL-6 or IL-1β/TNF-α does not induce apoptosis (n = 18--20 islets from five animals).\
(K and L) IL-1β/IL-6 and IL-1β/TNF-α decrease connexin-36 (*Gjd2*) mRNA levels (n = 10 animals).\
(M) IL-1β/IL-6 and IL-1β/TNF-α reduce the number of immunostained gap junction (connexin-36; Cx36) plaques (n = 9--12 islets from six animals) (scale bar, 12.5 μm).\
(N) Glucotoxicity (Glucotox) and glucolipotoxicity (Glucolipotox) reduce the proportion of hubs and correlated links in mouse islets (n = 6 animals).\
(O) As for (N), but showing effects of glucolipotoxicity-alone on human islets (n = 5 donors).\
Control, Con (buffer-alone). Data are means ± SEM. ^∗^p \< 0.05; ^∗∗^p \< 0.01. NS, non-significant. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.](gr7){#fig7}
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